The Hereditary Hemorrhagic Telangiectasia Center at Washington University School of Medicine is a center without walls.
This center formalizes an interest in HHT among a number of faculty members which has existed for more than 15 years and is the second largest center in the United States. During that time, we have treated a large number of patients with HHT and evaluated their family members. Clinician investigators at our institution developed the contrast echocardiogram as a method of screening for undiagnosed pulmonary arteriovenous malformations (PAVMs) and following treated PAVMs. Our center has treated more than 300 patients with PAVMs.
Our clinicians bring to bear all of the expertise currently available to treat HHT in a coordinated fashion. We will organize your visit so that you may see all necessary specialists and undergo all needed tests on a single visit.